HUMAN SPLEEN AS A SOURCE OF T CELL GROWTH FACTORMORETTA A; COLOMBATTI M; CHAPUIS B et al.1981; CLIN. EXP. IMMUNOL.; ISSN 0009-9104; GBR; DA. 1981; VOL. 44; NO 2; PP. 262-269; BIBL. 16 REF.Article

Interleukin-2 in clinical trials : Other factors to be considered. Authors' replyNANNINI, Esteban C; EMERY, Sean; LANE, H. Clifford et al.The Journal of infectious diseases. 2001, Vol 183, Num 4, pp 679-680, issn 0022-1899Article

Restoration of allogeneic responsiveness of lymphocytes from cyclosporin A-treated animals with interleukin 2BOSCO SHANG WANG; HEACOCK, E. H; CHANG-XUE ZHENG et al.Transplantation. 1982, Vol 33, Num 4, pp 454-456, issn 0041-1337Article

HUMAN T LYMPHOCYTES GROWN IN T-CELL GROWTH FACTOR: FUNCTIONAL ATTRIBUTES IN MLC, CML, PLT AND ALLOGENEIC SUPPRESSIONPAWELEC G; REHBEIN A; MUELLER C et al.1981; IMMUNOLOGY; ISSN 0019-2805; GBR; DA. 1981; VOL. 42; NO 4; PP. 529-540; BIBL. 22 REF.Article

A SIMPLIFIED METHOD FOR THE PRODUCTION OF MURINE T-CELL GROWTH FACTOR FREE OF LECTINSPIESS PJ; ROSENBERG SA.1981; J. IMMUNOL. METHODS; ISSN 0022-1759; NLD; DA. 1981; VOL. 42; NO 2; PP. 213-222; BIBL. 23 REF.Article

INTERLEUKIN 2 IN CELL-MEDIATED IMMUNE RESPONSESPAETKAU V; SHAW J; CAPLAN B et al.1980; J. SUPRAMOL. STRUCT.; ISSN 0091-7419; USA; DA. 1980; VOL. 13; NO 2; PP. 271-280; BIBL. 31 REF.Article

Secondary structure of interleukin-2 (Ala 125) in unfolded stateARAKAWA, T; KENNEY, W. C.International journal of peptide & protein research. 1988, Vol 31, Num 5, pp 468-473, issn 0367-8377Article

CONSTITUTIVE PRODUCTION OF INTERLEUKIN 2 ACTIVITY BY A T CELL HYBRIDOMASTULL D; GILLIS S.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 5; PP. 1680-1683; BIBL. 18 REF.Article

PROPERTIES OF SODIUM DODECYL SULFATE-DENATURED INTERLEUKIN 2CAPLAN B; GIBBS C; PAETKAU V et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 4; PP. 1351-1354; BIBL. 22 REF.Article

FUNCTIONAL AND MOLECULAR CHARACTERISTICS OF T-CELL GROWTH FACTORSMITH KA; BAKER PE; GILLIS S et al.1980; MOL. IMMUNOL.; GBR; DA. 1980; VOL. 17; NO 5; PP. 579-589; BIBL. 41 REF.Article

Formulation of liposomes associated with recombinant interleukin-2: effect on interleukin-2 activity : Drug delivery and drug efficacyPELLEQUER, Yann; OLLIVON, Michel; BARRATT, Gillian et al.Biomedicine & pharmacotherapy. 2004, Vol 58, Num 3, pp 162-167, issn 0753-3322, 6 p.Article

MACROPHAGE-INDEPENDANT ACTIVATION OF HELPER T CELLS. I: PRODUCTION OF INTERLEUKIN 2FARRAR JJ; MIZEL SB; FULLER FARRAR J et al.1980; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1980; VOL. 125; NO 2; PP. 793-798; BIBL. 34 REF.Article

REVISED NOMENCLATURE FOR ANTIGEN-NONSPECIFIC T CELL PROLIFERATION AND HELPER FACTORS1980; MOL. IMMUNOL.; GBR; DA. 1980; VOL. 17; NO 5; PP. 641-643; BIBL. 17 REF.Article

INTERLEUKIN 2 PRODUCTION BY BOTH LY2⁺ AND LY2^- T-CELL SUBSETSANDRUS L; PROWSE SJ; LAFFERTY KJ et al.1981; SCAND. J. IMMUNOL.; ISSN 0300-9475; NOR; DA. 1981; VOL. 13; NO 3; PP. 297-301; BIBL. 26 REF.Article

INHIBITION OF CONCANAVALIN A-INDUCED HUMAN LYMPHOCYTE MITOGENIC FACTOR (INTERLEUKIN-2) PRODUCTION BY SUPPRESSOR T LYMPHOCYTESNORTHOFF H; CARTER C; OPPENHEIM JJ et al.1980; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1980; VOL. 125; NO 4; PP. 1823-1828; BIBL. 27 REF.Article

Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumorsBOSLY, A; GUILLAUME, T; SYMANN, M et al.GUILLAUME, T; Experimental hematology. 1992, Vol 20, Num 8, pp 962-968, issn 0301-472XArticle

Serum interleukin-2 receptor levels measured by enzyme immunoassay in heart and kidney transplanted patientsDE MARIA, R; ZUCCHELLI, G. C; CLERICO, A et al.International journal of tissue reactions. 1989, Vol 11, Num 5, pp 261-265, issn 0250-0868, 5 p.Article

Chemical cross-linking of IL-2 to high affinity receptors present on glycerol-loaded T cells and membranes prepared from them yields only IL-2/P55 (Tac) complexesSIEKIERKA, J. J; DEGUDICIBUS, S; WADSWORTH, J et al.Annals of the New York Academy of Sciences. 1988, Vol 546, pp 230-231, issn 0077-8923Conference Paper

Modulation of the response to interleukin 2 in recipients of donor-specific transfusions under azathioprine immunosuppressionTYLER, J. D; ANDERSON, C. B; SICARD, G. A et al.Transplantation. 1986, Vol 42, Num 5, pp 502-506, issn 0041-1337Article

The effects of hemorrhage and trauma on interleukin 2 productionABRAHAM, E; REGAN, R. F.Archives of surgery (Chicago, IL. 1960). 1985, Vol 120, Num 12, pp 1341-1344, issn 0004-0010Article

Infection after subcutaneous interleukin-2BUTER, J; DE VRIES, E. G. E; SLEIJFER, D. T et al.Lancet (British edition). 1992, Vol 339, Num 8792, issn 0140-6736, p. 552Article

Ascites induced by interleukin-2 in the treatment of renal cancerTHOMAS, H; VALLIS, K. A; WILLIAMS, G et al.British journal of urology (Print). 1990, Vol 65, Num 3, pp 303-305, issn 0007-1331Article

Minireview serum inhibitors of interleukin-2KUCHARZ, E. J; GOODWIN, J. S.Life sciences (1973). 1988, Vol 42, Num 16, pp 1485-1491, issn 0024-3205Article

Structure-activity studies of interleukin-2COHEN, F. E; KOSEN, P. A; KUNTZ, I. D et al.Science (Washington, D.C.). 1986, Vol 234, Num 4774, pp 349-352, issn 0036-8075Article

Effect of interleukin-2 on the inhibition of the human mixed lymphocyte reaction (MLR) by azathioprineSZAWLOWSKI, P. W. S; MADDOCKS, J. L.British journal of clinical pharmacology. 1985, Vol 20, Num 2, pp 107-110, issn 0306-5251Article